These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9218984)

  • 41. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
    Harvey RJ; Sciulli CG; Mason RM; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
    [No Abstract]   [Full Text] [Related]  

  • 42. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B; Hill S; Beermann B; Post SG; Wimo A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic use of nicergoline.
    Winblad B; Fioravanti M; Dolezal T; Logina I; Milanov IG; Popescu DC; Solomon A
    Clin Drug Investig; 2008; 28(9):533-52. PubMed ID: 18666801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nootropics: pharmacological properties and therapeutic use.
    Gabryel B; Trzeciak HI
    Pol J Pharmacol; 1994; 46(5):383-94. PubMed ID: 7894524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 46. [Dementia: what the primary care physician must know about it].
    Wettstein A
    Praxis (Bern 1994); 2001 Oct; 90(40):1725-30. PubMed ID: 11680211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
    Wong VS
    Neurology; 2007 Aug; 69(8):809; author reply 809-10. PubMed ID: 17709718
    [No Abstract]   [Full Text] [Related]  

  • 49. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Amaducci L; Baldereschi M; Doody R; Chandra V; Gaines AD
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():19-21. PubMed ID: 9305509
    [No Abstract]   [Full Text] [Related]  

  • 50. Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network.
    Kornhuber J; Schmidtke K; Frolich L; Perneczky R; Wolf S; Hampel H; Jessen F; Heuser I; Peters O; Weih M; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Seuchter SA; Rüther E; Henn F; Maier W; Wiltfang J
    Dement Geriatr Cogn Disord; 2009; 27(5):404-17. PubMed ID: 19339779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anti-Alzheimer drugs: ethical aspects of research and practice].
    Berghmans RL
    Tijdschr Gerontol Geriatr; 2000 Jun; 31(3):100-6. PubMed ID: 10900662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 53. [Dementia therapy. Colleagues are very reticent about using drugs].
    MMW Fortschr Med; 2002 Apr; 144(17):50. PubMed ID: 12048856
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ginkgo extract in people with declining mental performance].
    Kaschel R
    Pharm Unserer Zeit; 2009; 38(5):432-9. PubMed ID: 19711319
    [No Abstract]   [Full Text] [Related]  

  • 55. [Nootropic drugs and their action mechanisms in relation to the neuropathobiology of senile dementia. I. Neurotransmission disorders in the brain].
    Benesová O
    Cesk Psychiatr; 1994 Aug; 90(4):191-200. PubMed ID: 7987928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
    Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
    Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nootropic drug evaluation for general practice].
    Ihl R; Kretschmar C
    Nervenarzt; 1997 Nov; 68(11):853-61. PubMed ID: 9732727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Challenging pharmacotherapy in dementia].
    Supprian T
    MMW Fortschr Med; 2008 May; 150 Suppl 2():33-6. PubMed ID: 18678049
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):119-22. PubMed ID: 21434467
    [No Abstract]   [Full Text] [Related]  

  • 60. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers.
    Post SG; Stuckey JC; Whitehouse PJ; Ollerton S; Durkin C; Robbins D; Fallcreek SJ
    Alzheimer Dis Assoc Disord; 2001; 15(2):80-8. PubMed ID: 11391089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.